June 2011

Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Conditions:   Neural Tube Defects;   Anemia;   Leukemia, Myeloid;   Bone Marrow Transplant Failure;   Myelodysplastic Syndromes (MDS);   Myeloproliferative Disorders
Interventions:   Drug: CIK cells;   Drug: Cyclosporine;   Drug: Mycophenolate Mofetil;   Drug: Thymoglobulin
Sponsor:   Everett Meyer
Active, not recruiting - verified December 2016